ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Cyclin E1 is a shared biomarker of subsets of high grade serous ovarian cancer (HGSOC) and basal like breast cancer (BLBC)
Annals of Oncology
◽
10.1093/annonc/mdz426.029
◽
2019
◽
Vol 30
◽
pp. ix86
Author(s):
D. Aziz
◽
C. Lee
◽
V. Chin
◽
K. Fernandez
◽
D. Etemadmoghadam
◽
...
Keyword(s):
Breast Cancer
◽
Ovarian Cancer
◽
High Grade
◽
Serous Ovarian Cancer
◽
Cyclin E1
◽
Basal Like Breast Cancer
Download Full-text
Related Documents
Cited By
References
Abstract P2-08-12: Development and validation of prognostic gene signatures for basal-like breast cancer and high grade serous ovarian cancer
10.1158/1538-7445.sabcs18-p2-08-12
◽
2019
◽
Author(s):
H Hu
◽
Y Zhang
◽
J Liu
◽
P-K Raj-Kumar
◽
H Yang
◽
...
Keyword(s):
Breast Cancer
◽
Ovarian Cancer
◽
High Grade
◽
Serous Ovarian Cancer
◽
Gene Signatures
◽
Prognostic Gene
◽
Basal Like Breast Cancer
◽
Development And Validation
Download Full-text
Development and validation of prognostic gene signature for basal-like breast cancer and high-grade serous ovarian cancer
Breast Cancer Research and Treatment
◽
10.1007/s10549-020-05884-z
◽
2020
◽
Vol 184
(3)
◽
pp. 689-698
Author(s):
Yi Zhang
◽
Jianfang Liu
◽
Praveen-Kumar Raj-Kumar
◽
Lori A. Sturtz
◽
Anupama Praveen-Kumar
◽
...
Keyword(s):
Breast Cancer
◽
Ovarian Cancer
◽
Gene Signature
◽
High Grade
◽
Serous Ovarian Cancer
◽
Prognostic Gene
◽
Prognostic Gene Signature
◽
Basal Like Breast Cancer
◽
Development And Validation
Download Full-text
Risk of high-grade serous ovarian cancer associated with pelvic inflammatory disease, parity and breast cancer
Cancer Epidemiology
◽
10.1016/j.canep.2018.05.011
◽
2018
◽
Vol 55
◽
pp. 110-116
◽
Cited By ~ 12
Author(s):
Louise M. Stewart
◽
Katrina Spilsbury
◽
Susan Jordan
◽
Colin Stewart
◽
C. D’Arcy J. Holman
◽
...
Keyword(s):
Breast Cancer
◽
Ovarian Cancer
◽
Pelvic Inflammatory Disease
◽
Inflammatory Disease
◽
High Grade
◽
Serous Ovarian Cancer
Download Full-text
Abstract CT324: Phase I of oral BKM120 or BYL719 and olaparib for high-grade serous ovarian cancer or triple-negative breast cancer: Final results of the BKM120 plus olaparib cohort
10.1158/1538-7445.am2015-ct324
◽
2015
◽
Cited By ~ 11
Author(s):
Ursula A. Matulonis
◽
Gerburg Wulf
◽
William Barry
◽
Michael Birrer
◽
Shannon Westin
◽
...
Keyword(s):
Breast Cancer
◽
Ovarian Cancer
◽
Phase I
◽
Triple Negative Breast Cancer
◽
Triple Negative
◽
High Grade
◽
Serous Ovarian Cancer
Download Full-text
298O The clinical significance of deregulated cyclin E1 in high grade serous ovarian cancer (HGSOC)
Annals of Oncology
◽
10.1093/annonc/mdw585.002
◽
2016
◽
Vol 27
(suppl_9)
◽
Author(s):
D. Aziz
◽
D. Etemadmoghadam
◽
G. Au-Yeung
◽
A. Muranyi
◽
I. Gresshoff
◽
...
Keyword(s):
Ovarian Cancer
◽
Clinical Significance
◽
High Grade
◽
Serous Ovarian Cancer
◽
Cyclin E1
Download Full-text
Evaluating the impact of a history of breast cancer on outcomes in women with high-grade serous ovarian cancer
Gynecologic Oncology
◽
10.1016/j.ygyno.2018.04.482
◽
2018
◽
Vol 149
◽
pp. 212
Author(s):
J. Gillen
◽
M. Rowland
◽
A.Y. Liu
◽
S. Vesely
◽
B. Powell
◽
...
Keyword(s):
Breast Cancer
◽
Ovarian Cancer
◽
High Grade
◽
Serous Ovarian Cancer
◽
History Of
◽
The Impact
Download Full-text
1PD A high throughput compound screen identifies potential combinations to overcome resistance to Cdk2 inhibitors in Cyclin E1 amplified high grade serous ovarian cancer
Annals of Oncology
◽
10.1093/annonc/mdv517.01
◽
2015
◽
Vol 26
◽
pp. ix1
Author(s):
G. Au-Yeung
◽
F. Lang
◽
C. Mitchell
◽
K. Jarman
◽
K. Lackovic
◽
...
Keyword(s):
Ovarian Cancer
◽
High Throughput
◽
High Grade
◽
Serous Ovarian Cancer
◽
Cyclin E1
Download Full-text
Evaluating the impact of a history of breast cancer on chemotherapy toxicities experienced in women with high grade serous ovarian cancer
Gynecologic Oncology
◽
10.1016/j.ygyno.2019.03.209
◽
2019
◽
Vol 154
(1)
◽
pp. e21
Author(s):
J. Gillen
◽
M. Enty
◽
M. Rowland
◽
J. Dvorak
◽
K. Ding
◽
...
Keyword(s):
Breast Cancer
◽
Ovarian Cancer
◽
High Grade
◽
Serous Ovarian Cancer
◽
History Of
◽
The Impact
Download Full-text
Abstract 156: Mutational signature 3 predicts responses to olaparib plus buparlisib in triple-negative breast cancer and high-grade serous ovarian cancer
10.1158/1538-7445.am2021-156
◽
2021
◽
Author(s):
Felipe Batalini
◽
Doga Gulhan
◽
Victor Mao
◽
Madeline Polak
◽
Eric P. Winer
◽
...
Keyword(s):
Breast Cancer
◽
Ovarian Cancer
◽
Triple Negative Breast Cancer
◽
Triple Negative
◽
High Grade
◽
Serous Ovarian Cancer
◽
Mutational Signature
Download Full-text
Abstract OT1-4-02: Phase I study of the combination of BKM120 and olaparib for the treatment of high grade serous ovarian cancer (HGSC) and triple negative breast cancer (TNBC)
10.1158/0008-5472.sabcs13-ot1-4-02
◽
2013
◽
Author(s):
UA Matulonis
◽
G Wulf
◽
L Cantley
◽
G Mills
◽
B Lasonde
◽
...
Keyword(s):
Breast Cancer
◽
Ovarian Cancer
◽
Phase I
◽
Triple Negative Breast Cancer
◽
Phase I Study
◽
Triple Negative
◽
High Grade
◽
Serous Ovarian Cancer
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close